Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction
Tóm tắt
Từ khóa
Tài liệu tham khảo
United States Renal Data System. Excerpts from the USRDS 2004 Annual Data Report. Am J Kidney Dis2005; 45 [Suppl 1]: S1–S280
Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med2002; 347: 2010–2019
Wanner C, Krane V, Marz W et al. Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics. Kidney Blood Press Res2004; 27: 259–266
Wrone EM, Hornberger JM, Zehnder JL, McCann LM, Coplon NS, Fortmann SP. Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol2004; 15: 420–426
Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int2003; 63: 793–808
Kaysen GA, Dubin JA, Muller HG, Mitch WE, Rosales LM, Levin NW. Relationships among inflammation, nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int2002; 61: 2240–2249
Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension2005; 45: 811–817
McGinlay JM, Payne RB. Serum albumin by dye-binding: bromocresol green or bromocresol purple? The case for conservatism. Ann Clin Biochem1988; 25: 417–421
Kalantar-Zadeh K, Kleiner M, Dunne E et al. Total iron-binding capacity-estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis1998; 31: 263–272
Kalantar-Zadeh K, Rodriguez RA, Humphreys MH. Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrol Dial Transplant2004; 19: 141–149
Reddan DN, Klassen PS, Szczech LA et al. White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant2003; 18: 1167–1173
Kuwae N, Kopple JD, Kalantar-Zadeh K. A low lymphocyte percentage is a predictor of mortality and hospitalization in hemodialysis patients. Clin Nephrol2005; 63: 22–34
Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure-time Data, 2nd edn. Wiley, New York; 2002
Greenland S. Applications of stratified analysis methods. In: Rothman K, Greenland S, eds. Modern Epidemiology, 2nd edn. Lipincott-Raven, Philadelphia: 1998
Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis1990; 15: 458–482
Kaysen GA, Chertow GM, Adhikarla R, Young B, Ronco C, Levin NW. Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int2001; 60: 333–340
Jurgens G, Muller M, Garidel P et al. Investigation into the interaction of recombinant human serum albumin with re-lipopolysaccharide and lipid A. J Endotoxin Res2002; 8: 115–126
Longenecker JC, Coresh J, Klag MJ et al. Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol2000; 11: 520–529
Kalender B, Mutlu B, Ersoz M, Kalkan A, Yilmaz A. The effects of acute phase proteins on serum albumin, transferrin and haemoglobin in haemodialysis patients. Int J Clin Pract2002; 56: 505–508
Goldwasser P, Kaldas AI, Barth RH. Rise in serum albumin and creatinine in the first half year on hemodialysis. Kidney Int1999; 56: 2260–2268